Warburg Pincus trims stake in China Biologic

The US private equity firm raises $241.5 million after paring stake in the Nasdaq-listed biopharmaceutical firm.

To continue reading, please login or register for free

Print Edition

FinanceAsia Print Edition

CONFERENCES